Johnson & Johnson (NYSE:JNJ) stock is presently standing at about $113.38 and lots of equity research firms seem to have a target price set on the stock. The median one-year price target of 18 analysts covering the company is $125.00, which suggests the stock could still rise over 9 percent. The highest analyst price target is $138.00, which implies a rally of 78 percent. And a quick view of analyst notes show that 6 are rating the stock a buy while 3 rate JNJ a strong buy. There are 14 equity research firms advocating a Hold and 0 consider it Sell.

Wells Fargo analysts provided their view on Johnson & Johnson (NYSE:JNJ) recently. The rating firm issued a Market Perform rating to this company in a research note released on Jan 26, 2017. Standpoint Research analysts disclosed their opinion on Johnson & Johnson (NYSE:JNJ) recently. The rating firm gave a Sell rating to this stock in a research note published on May 20, 2016. According to a research note disclosed on Mar 14, 2016, analysts at Goldman have upped their rating on these shares from Sell to Neutral.

Johnson & Johnson (NYSE:JNJ) Transactions Roundup

Several insiders were part of recent insider activity for the stock. Its Director PRINCE CHARLES Purchased 875 company shares for $99000.85, in a transaction on 2016-10-21. Following the transaction, the Director is left with a stake of 99.85 shares, currently valued at $11321. Meanwhile, Exec VP, Finance; CFO Caruso Dominic J sold 41,146 shares worth $5143000.66, through a transaction dated 2016-07-26. Following the completion of the transaction, the insider is left with a stake of 116,987 shares, amounting $13263986.06. JNJ Controller, CAO Kapusta Ronald A also sold 2,935 shares, at a stock price of $125.01. This transaction occurred on 2016-07-22 totals $366000.9. After this transaction, the insider’s stake stands at 26,443 shares, with a market value of $2998107.

Executives hold 0.10 percent of the stock. William C Weldon is one of the biggest insider owners in Johnson & Johnson (NYSE:JNJ), according to U.S. Securities and Exchange Commission (SEC) filings. The insider owns 307,273 shares which have current market value of around $34838612.74.Robert J. Darretta,Jr is another major inside shareholder in the company. The insider owns 207,118 shares as of less than 0.1%, currently worth $23483038.84. James T. Lenehan is ranked as third insider holder of the stock. This insider holds 198,157 shares with a market value around $22467040.66 as of recent close.

Johnson & Johnson (NYSE:JNJ) Earnings Outlook

In Johnson & Johnson (NYSE:JNJ)’s latest quarter, EPS moved to $1.58 from $1.68 in preceding quarter and revenues reached at $18,106.00M compared to $17,820.00M. Analysts had expected Johnson & Johnson (NYSE:JNJ) to post net income of about $1.56 per share on $18,275.20M in revenue. Looking ahead, analysts on average predict that earnings for the current quarter would come in in the range of $1.66 to $1.84. That is compared with the $1.68 in EPS it reported during the same period a year ago.